Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...

Medtronic's 780g insulin pump automates much ... blood glucose is a major advancement over the point-in-time blood glucose meters that typically provided two to four blood glucose readings in ...

Medtronic PLC investors have been content ... tools for diabetes management including insulin pumps and continuous glucose monitors, neuromodulation devices for chronic pain and movement disorders ...

Ford said he’s bullish about the company’s continuous glucose monitor unit, which grew by 21% for the quarter. In August, Abbott announced a partnership with Medtronic to make a continuous ...

Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now. The stock has ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

Last year, shares of DexCom (DXCM) and Abbott Laboratories (ABT), the leading developers of continuous glucose monitors (CGM) ...